Combination pharmacotherapy for the treatment of solid tumors

摘要

The present invention relates to a pharmaceutical combination comprising an IGF1R inhibitor and an mTOR inhibitor for the treatment of cancer in a subject; a pharmaceutical composition comprising such a combination; such for the preparation of a medicament for the treatment of cancer A kit comprising such a combination as a combined preparation for simultaneous use, individual use or sequential use; and a method of treating cancer in a subject, particularly a human.